Egyptian Cancer Society – ECS shared on LinkedIn:
“Precision medicine starts with precision testing.
The latest update to the Living Guidelines reinforces the importance of comprehensive biomarker testing before initiating first-line therapy in advanced NSCLC.
Other posts about ECS on OncoDaily.